Patents by Inventor Fred Ramsdell

Fred Ramsdell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110144309
    Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.
    Type: Application
    Filed: November 8, 2010
    Publication date: June 16, 2011
    Applicant: Celltech R&D, Inc.
    Inventors: Fred Ramsdell, Sean C. Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
  • Patent number: 7850968
    Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: December 14, 2010
    Assignee: Celltech R&D Limited
    Inventors: Fred Ramsdell, Sean C Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
  • Publication number: 20100081797
    Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.
    Type: Application
    Filed: October 2, 2009
    Publication date: April 1, 2010
    Applicant: CELLTECH R&D, INC.
    Inventors: Fred Ramsdell, Sean C. Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
  • Patent number: 7618629
    Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: November 17, 2009
    Assignee: Celltech R&D, Inc.
    Inventors: Fred Ramsdell, Sean C. Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
  • Publication number: 20090169543
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin and proteins that induce or inhibit Foxp3 expression.
    Type: Application
    Filed: November 6, 2008
    Publication date: July 2, 2009
    Applicant: UCB SA
    Inventors: Roli Khattri, Mary E. Brunkow, Fred Ramsdell
  • Patent number: 7507542
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin (Fkhsf) and proteins that induce or inhibit Scurfin or Foxp3 expression.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: March 24, 2009
    Assignee: UCB SA
    Inventors: Roli Khattri, Mary E Brunkow, Fred Ramsdell
  • Publication number: 20080131411
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Application
    Filed: April 16, 2007
    Publication date: June 5, 2008
    Applicant: UCB SA
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 7220579
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: May 22, 2007
    Assignee: UCB SA
    Inventors: Mary E Brunkow, Eric W Jeffery, Kathryn A Hjerrild, Fred Ramsdell
  • Patent number: 7135612
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: September 3, 2004
    Date of Patent: November 14, 2006
    Assignee: UCB SA
    Inventors: Mary E Brunkow, Eric W Jeffery, Kathryn A Hjerrild, Fred Ramsdell
  • Publication number: 20060083740
    Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.
    Type: Application
    Filed: November 21, 2002
    Publication date: April 20, 2006
    Applicant: Celltech R&D, Inc.
    Inventors: Fred Ramsdell, Sean Proll, Karen Staehling-Hampton, Mark Appleby, Leon Garcia-Martinez
  • Publication number: 20050164247
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Application
    Filed: November 15, 2004
    Publication date: July 28, 2005
    Applicant: Celltech R & D Limited
    Inventors: Mary Brunkow, Eric Jeffery, Kathryn Hjerrild, Fred Ramsdell
  • Publication number: 20050106601
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Application
    Filed: September 3, 2004
    Publication date: May 19, 2005
    Applicant: Celltech R & D Limited
    Inventors: Mary Brunkow, Eric Jeffery, Kathryn Hjerrild, Fred Ramsdell
  • Patent number: 6884618
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: April 26, 2005
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6794145
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: September 21, 2004
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6683160
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Assays that are based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), may be used for identifying numerous molecules that modulate the immune system. Molecules that specifically bind to an Fkhsf polypeptide are also provided as useful, such as, for modulating the biological activities of Fkhsf. In particular, antibodies that are specific for Fkhsf polypeptide are provided for uses such as for detecting the expression of an Fkhsf polypeptide in cells, isolating an Fkhsf polypeptide, and modulating the activity of an Fkhsf polypeptide.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: January 27, 2004
    Assignee: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6683171
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: January 27, 2004
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6667162
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: December 23, 2003
    Assignee: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Publication number: 20030170648
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin and proteins that induce or inhibit Foxp3 expression.
    Type: Application
    Filed: May 8, 2002
    Publication date: September 11, 2003
    Applicant: Darwin Molecular Corporation
    Inventors: Roli Khattri, Mary E. Brunkow, Fred Ramsdell
  • Publication number: 20020168736
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors.
    Type: Application
    Filed: April 2, 2002
    Publication date: November 14, 2002
    Applicant: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6414129
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors.
    Type: Grant
    Filed: August 11, 1999
    Date of Patent: July 2, 2002
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell